Benuvia Operations, LLC (Benuvia), a global contract development and manufacturing organization, today announced that it has been awarded a five-year contract by the National Institute on Drug Abuse ...

The contract will support R&D of high-quality APIs for substance use disorders and mental health conditions, starting with synthesis and scale-up of psilocybin, which is derived from mushrooms.

Benuvia will initially focus on the synthesis and scale-up of psilocybin, a Schedule I substance under the Controlled Substances Act that was granted Breakthrough Therapy designation by the U.S ...

Some words may be mispronounced. DES MOINES — Psilocybin, the psychoactive compound in “magic mushrooms,” could be administered to help treat post-traumatic stress disorder under a bill ...

Psilocybin, a psychedelic compound found in certain mushrooms, could offer a more cost-effective treatment option for major depressive disorder than current methods, according to research from ...

As they may only be isolable in small quantities, have interesting biological activity and chemical structures, natural product synthesis poses an interesting challenge in organic chemistry.

Psychedelic mushrooms and their psychoactive compound psilocybin have the potential to treat people with depression and anxiety, including those unresponsive to other medications or therapy. The ...